Navigation Links
Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
Date:8/26/2013

(PRWEB) August 26, 2013

According to a Consumer Update released by the FDA on August 1, 2013, Tylenol and other medicines containing acetaminophen have been linked to Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). These “are the two most serious skin reactions linked in rare cases to acetaminophen” and “they usually require hospitalization and can cause death.” These reactions begin with flu-like symptoms followed by a rash. In some cases, the rash can blister and cover large areas of the body causing scarring. Dr. Sharon Hertz, a deputy director at the FDA, stated that “it is extremely important that people recognize and react quickly to the initial symptoms of these rare but serious, side effects, which are potentially fatal" (i).

The FDA reviewed its adverse events database and discovered that there had been 107 cases of SJS and TEN resulting in 67 hospitalizations and 12 deaths. Based on this evidence, the Agency is requiring all prescription medicines containing acetaminophen to add a warning about skin reactions on their labels. The Agency stated that it would work with over the counter manufacturers to get similar labels on their medicines. Accurate and uniform labeling is an important part of consumer safety but many people may not know which over the counter drugs contain acetaminophen because the name is often shortened as “APAP,” “acet,” “acetamin,” or “acetaminoph” (i).

Attorney Paul d’Oliveira stated, “Fortunately, the FDA is finally recognizing the danger of SJS and TEN among commonly used drugs like Tylenol. Unfortunately, it is alleged that some drug manufacturers do not warn about these risks on the labels of their medicines. For many years nobody questioned the safety of Tylenol but recent reports suggest that liver damage and SJS are real dangers. Our law firm is investigating the possible allegations of manufacturing defects, design defects, and failure to warn and working with lawyers who are litigating these cases.”

Side effects of Tylenol can be very serious in some cases. People who have suffered liver or SJS injuries may be entitled to compensation for medical bills, lost income, pain and suffering, scarring, disfigurement, loss of consortium, or wrongful death. d’Oliveira & Associates has been investigating the link between widely used medicines and hypersensitivity reactions like SJS and TEN. The law firm works with some of the more experienced Tylenol lawyers, who are handling these cases, and there is no legal fee until a settlement or award is obtained. To contact the firm call 1-800-992-6878 or submit a contact form online.

(i) FDA Consumer Update, August 1, 2013.
fda.gov/ForConsumers/ConsumerUpdates/ucm363010.htm

Read the full story at http://www.prweb.com/releases/2013/8/prweb11043687.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Why is traumatic brain injury increasing among the elderly?
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Experts Offer Advice After Yankee Pitchers Trampoline Injury
5. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
6. Mild traumatic brain injury may contribute to brain network dysfunction
7. Injury-Linked Deaths Vary Widely Among States
8. Most occupational injury and illness costs are paid by the government and private payers
9. Diabetes drug could be a promising therapy for traumatic brain injury
10. Brain-Injury Recovery Varies Widely Among Children
11. Traumatic brain injury the focus of American Headache Society scientific conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... A quote from Dr. Edward Hallowell, host of CRN International’s “Distraction” podcast ... glimpse into the mind of those people with ADHD. , Dr. Hallowell, a child ... people with ADHD as having “Ferrari engines for a brain, with bicycle brakes.” , ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Cliff ... located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, ... treatment for a brain tumor. , Jason Bauer and his family are longtime ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, a New York-based firm ... Boroughs, is launching a charity drive to raise funds that will benefit the Marine ... of marines and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry ... through user experience. , BOC Global Events & Training Group is a professional ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to responses from U.S. oncologists that participated in ... with non-small cell lung cancer (NSCLC), treatment decisions are made ... status. The findings of the survey were presented today as ... ) at the 2016 World Conference on Lung Cancer (WCLC) ... survey results revealed an overall high rate of EGFR mutation ...
(Date:12/7/2016)... ALTO, Calif. , Dec. 7, 2016  Varian ... an update to its previously announced plans to separate ... be executed via a tax-free distribution to Varian stockholders ... stand-alone public company that will hold the Imaging Components ... expected to be executed by the end of January ...
(Date:12/7/2016)... , Dec. 7, 2016 Boehringer ... trial in patients with unresectable malignant pleural mesothelioma ... (PFS). The data, presented at the 17 th ... Vienna , showed nintedanib plus ... placebo plus pemetrexed/cisplatin, with a significantly improved PFS ...
Breaking Medicine Technology: